Cargando…

Use of Aspirin for Primary and Secondary Cardiovascular Disease Prevention in the United States, 2011–2012

BACKGROUND: Aspirin use has been shown to be an effective tool in cardiovascular disease (CVD) prevention among high‐risk patients. The patient‐reported physician recommendation for aspirin as preventive therapy among high‐ and low‐risk patients is unknown. METHODS AND RESULTS: We conducted an analy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mainous, Arch G., Tanner, Rebecca J., Shorr, Ronald I., Limacher, Marian C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310388/ https://www.ncbi.nlm.nih.gov/pubmed/25023071 http://dx.doi.org/10.1161/JAHA.114.000989

Ejemplares similares

Recent trends in the prevalence of low-dose aspirin use for primary and secondary prevention of cardiovascular disease in the United States, 2012–2015()
por: Stuntz, Mark, et al.
Publicado: (2016)

Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study
por: Mainous, Arch G, et al.
Publicado: (2014)

Receipt of Selected Clinical Preventive Services by Adults — United States, 2011–2012
por: Fox, Jared B., et al.
Publicado: (2015)

Will Technology and Artificial Intelligence Make the Primary Care Doctor Obsolete? Remember the Luddites
por: Mainous, Arch G.
Publicado: (2022)

Maintaining a Sufficient Primary Care Workforce: A Problem We Should Not Have
por: Mainous, Arch G.
Publicado: (2021)

Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
por: Djatche, Laurence M., et al.
Publicado: (2018)

Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
por: Spartalis, Michael, et al.
Publicado: (2023)

Aspirin for primary prevention of cardiovascular disease
por: Nansseu, Jobert Richie N., et al.
Publicado: (2015)

Aspirin for Primary Prevention of Cardiovascular Disease
por: Kim, Ji Hye, et al.
Publicado: (2019)

Prediabetes, elevated iron and all-cause mortality: a cohort study
por: Mainous, Arch G, et al.
Publicado: (2014)

Secondary Measures of Access to Abortion Services in the United States, 2011 and 2012: Gestational Age Limits, Cost, and Harassment
por: Jerman, Jenna, et al.
Publicado: (2014)

Underutilization of Aspirin Persists in US Ambulatory Care for the Secondary and Primary Prevention of Cardiovascular Disease
por: Stafford, Randall S, et al.
Publicado: (2005)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
por: Christensen, Mikkel B., et al.
Publicado: (2021)

Cardiovascular disease preventive effects of aspirin combined with different statins in the United States general population
por: Liu, Tao, et al.
Publicado: (2023)

Outbreaks of Illness Associated with Recreational Water — United States, 2011–2012
por: Hlavsa, Michele C., et al.
Publicado: (2015)

Aspirin overutilization for the primary prevention of cardiovascular disease
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Aspirin for the primary prevention of cardiovascular disease in the elderly
por: O’Sullivan, Jack W
Publicado: (2019)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
por: Coccheri, Sergio
Publicado: (2017)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017)

Aspirin Use among Adults with Cardiovascular Disease in the United States: Implications for an Intervention Approach
por: Ansa, Benjamin E., et al.
Publicado: (2019)

Changes in Children’s Oral Health Status and Receipt of Preventive Dental Visits, United States, 2003–2011/2012
por: Mandal, Mahua, et al.
Publicado: (2013)

Physicians should declare financial incentives for recruiting minority ethnic patients into clinical trials
por: Mainous, Arch G
Publicado: (2014)

Physician Weight Recommendations for Overweight and Obese Firefighters, United States, 2011–2012
por: Wilkinson, Michelle Lynn, et al.
Publicado: (2014)

Outbreaks Associated With Environmental and Undetermined Water Exposures — United States, 2011–2012
por: Beer, Karlyn D., et al.
Publicado: (2015)

Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review
por: Bem, Danai, et al.
Publicado: (2015)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence
por: Dimitriadis, Kyriakos, et al.
Publicado: (2022)

Changes in Cardiovascular Health in the United States, 2003–2011
por: Pilkerton, Courtney S, et al.
Publicado: (2015)

Is There Limited Utility for Lifestyle Recommendations for Diabetes Prevention Among Overweight or Obese Depressed Patients?
por: Mainous, Arch G., et al.
Publicado: (2021)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2007)

Pros and Cons of Aspirin for the Primary Prevention of Cardiovascular Events: A Secondary Study of Trial Sequential Analysis
por: Zhao, Binghao, et al.
Publicado: (2021)

Aspirin for cardiovascular disease prevention among adults in the United States: Trends, prevalence, and participant characteristics associated with use
por: Boakye, Ellen, et al.
Publicado: (2021)

Relationship of Income and Health Care Coverage to Receipt of Recommended Clinical Preventive Services by Adults — United States, 2011–2012
por: Fox, Jared B., et al.
Publicado: (2014)

Surveillance for Waterborne Disease Outbreaks Associated with Drinking Water — United States, 2011–2012
por: Beer, Karlyn D., et al.
Publicado: (2015)

Receipt and effectiveness of influenza vaccination reminders for adults, 2011‐2012 season, United States
por: Benedict, Katharine M., et al.
Publicado: (2018)

Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012
por: Vonnahme, Laura A., et al.
Publicado: (2019)

Cost or revenue: is diabetes prevention doomed due to misalignment of incentives?
por: Mainous 3rd, Arch G, et al.
Publicado: (2020)

Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings
por: Tan, Shi Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6m7f73fa1o15ggv5jgvo8mvebl